Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 13;51(1):803.
doi: 10.1007/s11033-024-09708-x.

Advances in development of biomarkers for brain damage and ischemia

Diana Karimova  1 , Elham Rostami  2 , Vladimir N Chubarev  3 , Vadim V Tarasov  3 , Helgi B Schiöth  1 , Mathias Rask-Andersen  4
Affiliations
Review

Advances in development of biomarkers for brain damage and ischemia

Diana Karimova et al. Mol Biol Rep. .

Abstract

Acquired brain injury is an urgent situation that requires rapid diagnosis and treatment. Magnetic resonance imaging (MRI) and computed tomography (CT) are required for accurate diagnosis. However, these methods are costly and require substantial infrastructure and specialized staff. Circulatory biomarkers of acute brain injury may help in the management of patients with acute cerebrovascular events and prevent poor outcome and mortality. The purpose of this review is to provide an overview of the development of potential biomarkers of brain damage to increase diagnostic possibilities. For this purpose, we searched the PubMed database of studies on the diagnostic potential of brain injury biomarkers. We also accessed information from Clinicaltrials.gov to identify any clinical trials of biomarker measurements for the diagnosis of brain damage. In total, we present 41 proteins, enzymes and hormones that have been considered as biomarkers for brain injury, of which 20 have been studied in clinical trials. Several microRNAs have also emerged as potential clinical biomarkers for early diagnosis. Combining multiple biomarkers in a panel, along with other parameters, is yielding promising outcomes.

Keywords: Biomarkers; Brain damage; Clinical trials; Ischemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Available from https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
    1. Budd SL (1998) Mechanisms of neuronal damage in Brain Hypoxia/Ischemia: Focus on the role of mitochondrial calcium Accumulation. Pharmacol Ther 80:203–229 - PubMed
    1. Allard L, Burkhard PR, Lescuyer P, Burgess JA, Walter N, Hochstrasser DF et al (2005) PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem 51:2043–2051 - PubMed
    1. Mingina T, Zhao M (2018) Role of PARK7 and NDKA in stroke management: a review of PARK7 and NDKA as stroke biomarkers. Biomark Med 12:419–425 - PubMed
    1. Matsuo R (2015) Research for biomarkers in ischemic stroke. Cereb Blood Flow Metabolism (Japanese J Cereb Blood flow Metabolism) 26:225–232

LinkOut - more resources